Found 8 matching trials
Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer
PHASE1This study is being done to select an appropriate TF2 bsMAb dose suitable f...
Location
Georgetown University Medical Center
TF2- Small Cell Lung Cancer Radio Immunotherapy
PHASE1Lung cancer is currently the leading cause of cancer death in both men and ...
Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer
PHASE1This study will investigate the toxicity, safety and pharmacokinetics of pr...
Location
Radboud University Nijmegen Medical Centre
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
PHASE1RATIONALE: Diagnostic procedures, such as radionuclide imaging using bispec...
Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer
PHASE2Evaluation of the sensitivity of the immuno-PET PET / CT pretargeted with t...
ImmunoTEP for Patients With Medullary Thyroid Carcinoma.
PHASE1The aim of this study is to optimize pretargeting parameters using pharmaco...
ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA
PHASE1Main objective: To determine the optimal molar doses of the biospecific ant...
Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer
PHASE1Phase I/II, Open-labeled, Prospective, Multi-center study of a Pretargeted ...